258 related articles for article (PubMed ID: 29185159)
1. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
[TBL] [Abstract][Full Text] [Related]
2. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
3. Influence of hormones and hormone metabolites on the growth of Schwann cells derived from embryonic stem cells and on tumor cell lines expressing variable levels of neurofibromin.
Roth TM; Ramamurthy P; Muir D; Wallace MR; Zhu Y; Chang L; Barald KF
Dev Dyn; 2008 Feb; 237(2):513-24. PubMed ID: 18213578
[TBL] [Abstract][Full Text] [Related]
4. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive NF1 screening on cultured Schwann cells from neurofibromas.
Maertens O; Brems H; Vandesompele J; De Raedt T; Heyns I; Rosenbaum T; De Schepper S; De Paepe A; Mortier G; Janssens S; Speleman F; Legius E; Messiaen L
Hum Mutat; 2006 Oct; 27(10):1030-40. PubMed ID: 16941471
[TBL] [Abstract][Full Text] [Related]
6. The development of cutaneous neurofibromas.
Jouhilahti EM; Peltonen S; Callens T; Jokinen E; Heape AM; Messiaen L; Peltonen J
Am J Pathol; 2011 Feb; 178(2):500-5. PubMed ID: 21281783
[TBL] [Abstract][Full Text] [Related]
7. Schwann cells harbor the somatic NF1 mutation in neurofibromas: evidence of two different Schwann cell subpopulations.
Serra E; Rosenbaum T; Winner U; Aledo R; Ars E; Estivill X; Lenard HG; Lázaro C
Hum Mol Genet; 2000 Dec; 9(20):3055-64. PubMed ID: 11115850
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of neurofibromin contributes to epithelial-mesenchymal transition in neurofibromatosis type 1.
Arima Y; Hayashi H; Kamata K; Goto TM; Sasaki M; Kuramochi A; Saya H
Exp Dermatol; 2010 Aug; 19(8):e136-41. PubMed ID: 20002172
[TBL] [Abstract][Full Text] [Related]
9. The activation of the WNT signaling pathway is a Hallmark in neurofibromatosis type 1 tumorigenesis.
Luscan A; Shackleford G; Masliah-Planchon J; Laurendeau I; Ortonne N; Varin J; Lallemand F; Leroy K; Dumaine V; Hivelin M; Borderie D; De Raedt T; Valeyrie-Allanore L; Larousserie F; Terris B; Lantieri L; Vidaud M; Vidaud D; Wolkenstein P; Parfait B; Bièche I; Massaad C; Pasmant E
Clin Cancer Res; 2014 Jan; 20(2):358-71. PubMed ID: 24218515
[TBL] [Abstract][Full Text] [Related]
10. Neurofibromin-deficient Schwann cells have increased lysophosphatidic acid dependent survival and migration-implications for increased neurofibroma formation during pregnancy.
Nebesio TD; Ming W; Chen S; Clegg T; Yuan J; Yang Y; Estwick SA; Li Y; Li X; Hingtgen CM; Yang FC
Glia; 2007 Apr; 55(5):527-36. PubMed ID: 17236191
[TBL] [Abstract][Full Text] [Related]
11. KIR2DL5 mutation and loss underlies sporadic dermal neurofibroma pathogenesis and growth.
Anastasaki C; Dahiya S; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47574-47585. PubMed ID: 28548933
[TBL] [Abstract][Full Text] [Related]
12. Cellular Origin, Tumor Progression, and Pathogenic Mechanisms of Cutaneous Neurofibromas Revealed by Mice with
Radomska KJ; Coulpier F; Gresset A; Schmitt A; Debbiche A; Lemoine S; Wolkenstein P; Vallat JM; Charnay P; Topilko P
Cancer Discov; 2019 Jan; 9(1):130-147. PubMed ID: 30348676
[TBL] [Abstract][Full Text] [Related]
13. Spatiotemporal Loss of
Chen Z; Mo J; Brosseau JP; Shipman T; Wang Y; Liao CP; Cooper JM; Allaway RJ; Gosline SJC; Guinney J; Carroll TJ; Le LQ
Cancer Discov; 2019 Jan; 9(1):114-129. PubMed ID: 30348677
[TBL] [Abstract][Full Text] [Related]
14. Neurofibromin-deficient Schwann cells secrete a potent migratory stimulus for Nf1+/- mast cells.
Yang FC; Ingram DA; Chen S; Hingtgen CM; Ratner N; Monk KR; Clegg T; White H; Mead L; Wenning MJ; Williams DA; Kapur R; Atkinson SJ; Clapp DW
J Clin Invest; 2003 Dec; 112(12):1851-61. PubMed ID: 14679180
[TBL] [Abstract][Full Text] [Related]
15. P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis.
Patritti Cram J; Wu J; Coover RA; Rizvi TA; Chaney KE; Ravindran R; Cancelas JA; Spinner RJ; Ratner N
Elife; 2022 Mar; 11():. PubMed ID: 35311647
[TBL] [Abstract][Full Text] [Related]
16. Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins.
Mo J; Anastasaki C; Chen Z; Shipman T; Papke J; Yin K; Gutmann DH; Le LQ
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33108355
[TBL] [Abstract][Full Text] [Related]
17. Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.
Yang FC; Ingram DA; Chen S; Zhu Y; Yuan J; Li X; Yang X; Knowles S; Horn W; Li Y; Zhang S; Yang Y; Vakili ST; Yu M; Burns D; Robertson K; Hutchins G; Parada LF; Clapp DW
Cell; 2008 Oct; 135(3):437-48. PubMed ID: 18984156
[TBL] [Abstract][Full Text] [Related]
18. Neurofibroma-associated growth factors activate a distinct signaling network to alter the function of neurofibromin-deficient endothelial cells.
Munchhof AM; Li F; White HA; Mead LE; Krier TR; Fenoglio A; Li X; Yuan J; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1858-69. PubMed ID: 16648142
[TBL] [Abstract][Full Text] [Related]
19. In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
Fishbein L; Zhang X; Fisher LB; Li H; Campbell-Thompson M; Yachnis A; Rubenstein A; Muir D; Wallace MR
Mol Carcinog; 2007 Jul; 46(7):512-23. PubMed ID: 17393410
[TBL] [Abstract][Full Text] [Related]
20. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]